Status:

RECRUITING

Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing

Lead Sponsor:

Virginia Polytechnic Institute and State University

Collaborating Sponsors:

Roswell Park Comprehensive Cancer Center

National Cancer Institute (NCI)

Conditions:

Cigarette Smoking

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

This study will investigate the effects of normal-nicotine versus low-nicotine cigarette availability in the context of four tax proposals (Tobacco Parity, Nicotine-Content, Harm-Reduction, and Modifi...

Detailed Description

In a within/between subjects design, the investigators will use an Experimental Tobacco Marketplace (ETM) to systematically impose four innovative tobacco/nicotine tax proposals (Tobacco Parity, Nicot...

Eligibility Criteria

Inclusion

  • provide informed consent
  • provide a breath carbon monoxide sample ≥ 8 ppm,
  • be at least 21 years of age (the legal age to purchase tobacco),
  • smoke at least 10 cigarettes daily, and
  • use other tobacco products less than weekly.

Exclusion

  • report uncontrolled physical or mental health conditions (e.g., uncontrolled diabetes, high blood pressure, major depressive disorder, etc.),
  • use of smoking cessation medications (e.g., nicotine replacement, bupropion, varenicline) in the past 30 days,
  • report concrete, immediate plans to alter/quit using their usual tobacco products in the next 30 days,
  • be pregnant or lactating, or
  • have plans to move out of the area during the experiment.

Key Trial Info

Start Date :

August 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

316 Patients enrolled

Trial Details

Trial ID

NCT07142668

Start Date

August 15 2025

End Date

July 1 2026

Last Update

September 5 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Roswell Park Comprehensive Cancer Center

Buffalo, New York, United States, 14263

2

Fralin Biomedical Research Institute at VTC

Roanoke, Virginia, United States, 24016